Safeguard Scientifics, Inc.

SFES Financial Asset Management

EPS
−121.7%
Free cash flow
+42.7%

Quarter to June 2026, against a year earlier

0.60 0.02 +3.45%
Market cap
$7.5M
P/E
0.5×
Fwd P/E
—
Dividend yield
0.00%
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 26.57%

Capital & Financial Ratios $m

Size
Market Cap 7.54
Revenue ttm —
Net income ttm 1.73
Free cash flow ttm (1.26)
Net debt Q (4.84)
Valuation
P/E 0.52
Forward P/E —
Price / sales 0.00
Forward P/S Powerpack
Price / FCF 0.00
Price / book 1.61
Financial health
Current ratio Q 8.07
Debt / equity Q 0.00
Interest coverage Q (7.40)
Growth
Revenue growth Q —
Operating income growth Q +23.38% (above 0%: growing)
EPS, this year —
EPS, next year A —
Revenue, next year A —
EPS, past 5 yrs —
EPS, next 5 yrs A —

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/B against its own 10 years 55.76%
10-year low 10-year high

Dividends

Yield
0.00%
Annual rate
0.00
Payout ratio
0.00%

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 10 7 9 5
Receivables — — — —
Inventory — — — —
Other — — — —
10 7 9 5
2023 2024 2025 Q'26
Payables 0 0 0 0
ST’ Debt — — — —
Other — — — —
2 1 1 1

Compound Annual Growth %

10y 5y 3y
Sales — — —
Cash Flow 0.00% 0.00% 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value (24.64%) (28.74%) (30.61%)

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 1.10 (0.02) — — —
’25 (0.05) 0.07 0.10 (0.02) 0.10
’24 (0.12) (0.10) (0.07) (0.33) (0.62)
’23 (0.22) (0.18) 0.06 (0.27) (0.61)
’22 (0.40) 0.03 (0.19) (0.30) (0.87)
’21 0.84 (0.02) 0.88 (0.51) 1.36
’20 (0.77) (0.48) (0.21) (0.35) (1.81)
Fiscal quarters ending in the months shown.

Revenue $m

Year
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 0 (1) — — —
’25 0 (1) 0 0 (2)
’24 (1) (1) 0 0 (3)
’23 (1) (1) 0 (1) (3)
’22 (1) (1) (1) (1) (3)
’21 (2) (3) (1) (3) (8)
’20 (3) (3) (1) (1) (8)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 0 (1) — — —
’25 0 (1) 0 0 (2)
’24 (1) (1) 0 0 (3)
’23 (1) (1) 0 (1) (3)
’22 (1) (1) (1) (1) (3)
’21 (2) (3) (1) (3) (8)
’20 (3) (3) (1) (1) (8)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — — — — — — — — — — — — — — —
Gross margin, % 0.00 0.00 0.00 0.00 0.00 0.00 0.00 — — — — 0.0 pt
EBT (22) (89) (16) 55 (38) 27 (14) (10) (10) 2 19 n/m
EBT margin, % 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0 pt
Net income (22) (89) (16) 55 (38) 27 (14) (10) (10) 2 2 n/m
Per share, $
Per share, $ Revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 n/m
Earnings (1.09) (4.34) (0.76) 2.64 (1.81) 1.36 (0.87) (0.61) (0.62) 0.10 1.16 n/m
Cash flow (0.92) (1.02) (1.27) (0.97) (0.39) (0.41) (0.20) (0.20) (0.18) (0.11) (0.08) (21.3%)
Capex (0.02) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 n/m
Free cash flow (0.94) (1.02) (1.27) (0.97) (0.39) (0.41) (0.20) (0.20) (0.17) (0.11) (0.08) (21.5%)
Book value 8.35 4.00 3.26 4.93 3.03 2.55 2.12 1.23 0.59 0.69 0.37 (24.2%)
Shares, m 20 20 21 21 21 20 16 16 17 17 17 (2.2%)
Valuation, ×
Valuation, × P/E — — — — — — — — — — 0 —
P/S — — — — — — — — — — 0 —
P/B — — — — — — — — — — 0 —
EV/Sales — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — —
Cash, $m
Cash, $m Operating cash flow (19) (21) (26) (20) (8) (8) (3) (3) (3) (2) (1) (23.0%)
Capex 0 — 0 — — — — — 0 — 0 n/m
Free cash flow (19) (21) (26) (20) (8) (8) (3) (3) (3) (2) (1) (23.2%)
Balance, $m
Balance, $m Working capital 27 (12) 14 24 13 29 20 8 6 8 4 (12.2%)
Net debt 22 57 24 (25) (16) (25) (19) (10) (7) (9) (5) n/m
Shareholders’ equity 170 82 67 102 63 51 35 20 10 12 6 (25.8%)
Returns, %
Returns, % ROA (9.11) (43.39) (9.70) 43.08 (42.60) 43.89 (31.10) (32.47) (60.84) 14.48 214.23 +23.6 pt
ROIC (6.09) (7.72) (11.59) (8.14) (12.51) (17.33) (19.55) (33.95) (54.53) (50.98) (84.13) (44.9) pt
ROE (12.19) (70.41) (21.01) 64.68 (45.70) 47.61 (33.50) (36.03) (69.68) 16.14 237.38 +28.3 pt
People
People Employees 33 33 — — — — — — — — — 0.0%
Revenue/emp, $m 0.00 0.00 — — — — — — — — — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2009 · latest quarter Dec 2009 · fundamentals updated 25 Oct 2026

Safeguard Scientifics, Inc. vs peers in Asset Management (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
INV Innventure, Inc. $13.7M — (loss-making) — +100.21% (above 0%: growing) n/m −16.26% (below 0%: shrinking) (432.32%) (3,304.09%) Compare
BENF Beneficient $13.2M — (loss-making) — (loss-making) +196.37% (above 0%: growing) n/m +62.45% (above 0%: growing) 100.00% 34.47% Compare
AMTD AMTD IDEA Group $11.0M 11.0× — (loss-making) +90.59% (above 0%: growing) −31.02% (below 0%: shrinking) — 0.00% 0.00% Compare
EQS Equus Total Return, Inc. $8.9M — (loss-making) 32.9× −10.92% (below 0%: shrinking) n/m +113.19% (above 0%: growing) 100.00% (266.98%) Compare
ICMB Investcorp Credit Management BDC, Inc. $8.8M — (loss-making) 20.5× −31.05% (below 0%: shrinking) n/m +238.07% (above 0%: growing) 100.00% 59.40% Compare
SFES Safeguard Scientifics, Inc. $7.5M 0.5× — — n/m +42.68% (above 0%: growing) 0.00% 0.00%
TWAV TaoWeave, Inc. $4.8M — (loss-making) 12.4× −11.82% (below 0%: shrinking) n/m +107.53% (above 0%: growing) 52.49% (161.11%) Compare
ALP Alpha Compute Corp $4.6M — (loss-making) — (loss-making) — n/m +66.68% (above 0%: growing) 0.00% 0.00% Compare
CWD CaliberCos Inc. $4.3M — (loss-making) — (loss-making) −17.33% (below 0%: shrinking) n/m −126.92% (below 0%: shrinking) 100.00% (98.97%) Compare
Median of peers $8.9M — 20.5× −10.92% — +66.68% 76.25% (49.48%)

All 121 Asset Management stocks →

Pay and ownership Proxy statement filed 2 November 2023

Ownership

Directors and executive officers, together 9.70%
Thomas A. Satterfield, Jr. 12.60%
Contrarian Capital Management, L.L.C. 7.20%
First Manhattan Co. 7.20%
Yakira Partners, L.P., Yakira Enhanced Offshore Fund Ltd. and MAP 7.00%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Safeguard Scientifics, Inc. (SFES) Latest News

14 Nov

Impact 3 · · Associated Press Finance

14 Aug

Impact 3 · · Associated Press Finance
stockrow.com/SFES · Data as of Oct 25, 2026 · For information only; not investment advice. · © 2026 stockrow.com